Showing 1 - 3 results of 3 for search 'James Tumlin', query time: 0.01s Refine Results
  1. 1
    Targeting the Type I Interferon Pathway in Glomerular Kidney Disease: Rationale and Therapeutic Opportunities

    Targeting the Type I Interferon Pathway in Glomerular Kidney Disease: Rationale and Therapeutic Opportunities by James Tumlin, Brad Rovin, Hans-Joachim Anders, Eduardo F. Mysler, David R.W. Jayne, Tsutomu Takeuchi, Catharina Lindholm, Gudrun Weiss, Alessandro Sorrentino, Kevin Woollard, Nicola Ferrari

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    WCN24-762 UPDATED RESULTS FROM THE RUBY-3 STUDY OF POVETACICEPT, AN ENHANCED DUAL BAFF/APRIL ANTAGONIST, IN AUTOANTIBODY-ASSOCIATED GLOMERULONEPHRITIS

    WCN24-762 UPDATED RESULTS FROM THE RUBY-3 STUDY OF POVETACICEPT, AN ENHANCED DUAL BAFF/APRIL ANTAGONIST, IN AUTOANTIBODY-ASSOCIATED GLOMERULONEPHRITIS by James Tumlin, Sreedhar Mandayam, Arvind Madan, Frank Cortazar, Sang-Woong Han, Hemant Kulkarni, Jonathan Barratt, Brad Rovin, Hong Zhang, Rupert Davies, Amanda Enstrom, Heather Thomas, Jiahua Li, Stanford L. Peng, Harmeet Singh

    Published 2024-04-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    WCN24-756 POVETACICEPT, AN ENHANCED DUAL BAFF/APRIL ANTAGONIST, IN AUTOANTIBODY-ASSOCIATED GLOMERULONEPHRITIS

    WCN24-756 POVETACICEPT, AN ENHANCED DUAL BAFF/APRIL ANTAGONIST, IN AUTOANTIBODY-ASSOCIATED GLOMERULONEPHRITIS by James Tumlin, Sreedhar Mandayam, Arvind Madan, Frank Cortazar, Sang-Woong Han, Hemant Kulkarni, Jonathan Barratt, Brad Rovin, Hong Zhang, Rupert Davies, Amanda Enstrom, Heather Thomas, Jiahua Li, Stanford L. Peng, Harmeet Singh

    Published 2024-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: